Bevacizumab/Cisplatin/Irinotecan Regimen

Preferred Label : Bevacizumab/Cisplatin/Irinotecan Regimen;

NCIt synonyms : Irinotecan/Bevacizumab/Cisplatin; Bevacizumab/Cisplatin/Irinotecan; Irinotecan/Bevacizumab/Platinol; Irinotecan-Bevacizumab-Cisplatin; IBP;

NCIt related terms : IPB;

NCIt definition : A regimen consisting of bevacizumab, cisplatin, and irinotecan that may be used in the treatment of certain gastric cancers and small-cell lung cancers (SCLC).;

Détails

Origin ID

C161974;

UMLS CUI

C1541235;

Automatic exact mappings (from CISMeF team)
- Invasive blood pressure (observable entity) [SNOMED CT concept]
False automatic mappings
- Def6 guanine nucleotide exchange factor [OMIM gene]
- O,O-diisopropyl-S-benzylthiophosphate [MeSH Supplementary Concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Cisplatin [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database-Regimen [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients